'Cross resistance' presentation slideshows

Najcz?stsze b??dy w post?powaniu z chorym po niepowodzeniach terapeutycznych

1.01k views • 90 slides

Najcz?stsze b??dy w post?powaniu z chorym po niepowodzeniach terapeutycznych

1k views • 90 slides

HIV-1 Resistance - Implications For Clinicians

HIV-1 Resistance - Implications For Clinicians. Joseph J. Eron Jr., MD Professor of Medicine University of North Carolina. Disclosures. Types of Resistance Tests. Genotype and Phenotype. Types of Resistance Tests. Genotype

405 views • 29 slides

innovir Institute

bringing science to life. innovir Institute. ANTIRETROVIRAL RESISTANCE IN CLINICAL PRACTICE. Steven Miller Medical Director. Classes of ARVs. NRTIs - AZT, d4T, ddI, abacavir, 3TC, FTC, tenofovir (Target enzyme: Reverse Transcriptase)

287 views • 28 slides

RITONAVIR INTERACTIONS AND SIDE EFFECTS

RITONAVIR INTERACTIONS AND SIDE EFFECTS. Present by PEERAKARN BANJERDKIJ. OUTLINE. Introduction HIV Therapy Types of HIV-drugs Protease Inhibitors work Ritonavir Pharmacology Drug Interactions Side effects Conclusion. INTRODUCTION.

370 views • 22 slides

RITONAVIR INTERACTIONS AND SIDE EFFECTS

RITONAVIR INTERACTIONS AND SIDE EFFECTS. Present by PEERAKARN BANJERDKIJ. OUTLINE. Introduction HIV Therapy Types of HIV-drugs Protease Inhibitors work Ritonavir Pharmacology Drug Interactions Side effects Conclusion. INTRODUCTION.

337 views • 22 slides

336 views • 21 slides

FRAC CAA Working GROUP 1 st Meeting Sheraton Airport Hotel Frankfurt 27th October 2005

FRAC CAA Working GROUP 1 st Meeting Sheraton Airport Hotel Frankfurt 27th October 2005 hosting company: BASF. Meeting 27th October 2005 Sheraton Airport Hotel, Frankfurt, Germany. Participants: BASF: Randall Gold, Kristin Klappach , Gerd Stammler

332 views • 18 slides

Contact Toxicity of Spinosad to Adult Stored-Product Beetles and a Parasitoid

Contact Toxicity of Spinosad to Adult Stored-Product Beetles and a Parasitoid. Michael Toews Dept. of Grain Science and Industry Kansas State University. Spinosad. Metabolite of the actinomycete bacterium Saccharopolyspora spinosa

657 views • 14 slides

Constructing a regimen

Constructing a regimen. Session 5. Principles of designing an MDR-TB treatment regimen.

308 views • 11 slides

Resistance defined by WHO

Resistance defined by WHO. The ability in a strain of some organism to tolerate doses of a toxicant which would prove lethal majority of individuals in a normal population of the same species. Resistance defined by A.W.A. Brown.

114 views • 11 slides